Amit Munshi, Chief Executive Officer at EPIRUS Biopharmaceuticals, Inc. (EPRS), bought 10,000 shares at $6.19 ($62K) on 2015-09-21, disclosed to the SEC on 2015-09-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| ZURA | BUY | 2023-06-05 | $1000K | — | Filing → |
| ARNA | BUY | 2021-08-17 | $48K | — | Filing → |
| ARNA | BUY | 2021-08-13 | $50K | — | Filing → |